The Lyng Lab works to develop biomarkers and drug targets in radiotherapy of cancer. We are located at Institute for Cancer Research, Oslo University Hospital.
Prof Gillies McKenna highlights several exciting prospects for particle therapy: differences in immune response, radio sensitisers, FLASH & microbeam (more understanding needed) & solving bottlenecks in treatment planning via artificial intelligence and machine learning #PTCOG58